Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
- Resource Type
- Article
- Authors
- Kessoku, Takaomi; Imajo, Kento; Kobayashi, Takashi; Ozaki, Anna; Iwaki, Michihiro; Honda, Yasushi; Kato, Takayuki; Ogawa, Yuji; Tomeno, Wataru; Kato, Shingo; Higurashi, Takuma; Yoneda, Masato; Kirikoshi, Hiroyuki; Kubota, Kazumi; Taguri, Masataka; Yamanaka, Takeharu; Usuda, Haruki; Wada, Koichiro; Kobayashi, Noritoshi; Saito, Satoru; Nakajima, Atsushi
- Source
- In The Lancet Gastroenterology & Hepatology November 2020 5(11):996-1007
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2468-1253